Generally, the affected individuals with MMDS4 are characterized by neurodegeneration, developmental regression, failure to thrive, quadriplegia, truncal hypotonia, optic atrophy, and leukoencephalopathy (8, 13). This evidence concerns the gene ISCA2 and optic atrophy.